On 13 February, at
The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi's website prior to the telephone conference.
To participate in the telephone conference, please call:
SE: +46 8 505 583 55
US: +1 646 722 4902
Click here to go to the live webcast. (https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=&eventid=2172532&sessionid=1&key=64FA3B636320F32DF4CA98068F533D74®Tag=&sourcepage=register)
After the live event the webcast will be available on-demand via the same URL.
---
About Sobi™
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,300 people across
For more information please contact
Paula Treutiger, Head of Communication & Investor Relations
+ 46 733 666 599
paula.treutiger@sobi.com
+ 46 708 734 095
linda.holmstrom@sobi.com
Postal address SE-112 76
Phone: 46 8 697 20 00 www.sobi.com
https://news.cision.com/swedish-orphan-biovitrum-ab/r/invitation---presentation-of-sobi-s-q4-fy-2019-results,c3026803
https://mb.cision.com/Main/14266/3026803/1187629.pdf
(c) 2020 Cision. All rights reserved., source